Audiological findings in Usher syndrome types IIa and II (non-IIa)

International Journal of Audiology

Volumn 43, Issue 3, 2004, Pages 136-143

  Sadeghi, Mehdi ^a   Cohn, Edward S ^b   Kelly, William J ^b   Kimberling, William J ^b   Tranebjærg, Lisbeth ^c   Möller, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Hereditary hearing loss; Progressive hearing loss; Recessive syndromic hearing loss; Usher syndrome; Usher syndrome type II

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUDIOGRAPHY; AUDIOLOGY; CHILD; FEMALE; GENE; GENE MUTATION; GENETIC LINKAGE; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RETINITIS PIGMENTOSA; USHER SYNDROME;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HEARING LOSS; HUMANS; MALE; MIDDLE AGED; RETINITIS PIGMENTOSA; SYNDROME; TINNITUS; VERTIGO;

EID: 1642391516     PISSN: 14992027     EISSN: None     Source Type: Journal    
DOI: 10.1080/14992020400050019     Document Type: Article

References (27)

1. Bell, J. 1933. Retinitis pigmentosa and allied diseases. In: K. Pearson (ed.) Treasury of Human Inheritance, 1st edn, Vol. 2. London: Cambridge University Press, pp. 1-29.
2. Boughman, J.A., Vernon, M. & Shaver, K.A. 1983. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis, 36, 595-603.
3. Dreyer, B., Tranebjaerg, L., Brox, V., Rosenberg, T., Möller, C., et al. 2001. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet, 69, 228-234.
4. Eudy, J.D., Weston, M.D., Yao, S., Hoover, D.M., Rehm, H.L., et al. 1998. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science, 280, 1753-1757.
5. Grondahl, J. 1987. Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet, 31, 255-264.
6. Hallgren, B. 1959. Retinitis pigmentosa combined with congenital deafness; with vestibulo-cerebellar ataxia and mental abnormality in a proportion of cases. A clinical and genetico-statistical study. Acta Psychiatr Neurol Scand, 34(suppl 138), 1-101.
7. Hmani-Aifa, M., Ben Arab, S., Kharrat, K., Orten, D.J., Boulila-Elgaied, A., et al. 2002. Distinctive audiometric features between USH2A and USH2B subtypes of Usher syndrome. J Med Genet, 39, 281-283.
8. Hope, C.I., Bundey, S., Proops, D. & Fielder, A.R. 1997. Usher syndrome in the city of Birmingham - prevalence and clinical classification. Br J Ophthalmol, 81, 46-53.
9. International Organization for Standardization. 1989. Acoustics - Audiometric Test Methods Part 1: Basic Pure Tone Air and Bone Conduction Threshold Audiometry. ISO 8253-1. Geneva: ISO.
10. International Organization for Standardization. 2000. Acoustics-Threshold of Hearing by Air Conduction as a Function of Age and Sex for Otologically Normal Persons. ISO 7029. Geneva: ISO.
11. Kaplan, J., Guasconi, G., Bonneau, D., Melki, J., Briard, M.L., et al. 1990. Usher syndrome type I is not linked to DIS81 (pTHH 33): evidence for genetic heterogeneity. Ann Genet, 33, 105-108.
12. Kimberling, W.J., Möller, C.G., Davenport, S.L., Lund, G., Grissom, T.J., et al. 1989. Usher syndrome: clinical findings and gene localization studies. Laryngoscope, 99, 66-72.
13. Kimberling, W.J., Orten, D.J. & Pieke Dahl, S. 2000. Genetic heterogeneity of Usher syndrome. Adv Otorhinolaryngol, 56, 11-18.
14. Kimberling, W.J., Weston, M.D., Möller, C., Davenport, S.L., Shugart, Y.Y., et al. 1990. Localization of Usher syndrome type II to chromosome 1q. Genomics, 7, 245-249.
15. Martini, A., Stephens, D., Parving, A., Petit, C., Cremers, C., et al. 1996. Hereditary Deafness, Epidemiology and Clinical Research. A Project from European Commission Directorate - General XII - Science, Research and Development Biomedical and Health Research Programme (Biomed 2) Biomedical Technologies. Ferrara: HEAR Project.
16. Möller, C.G., Kimberling, W.J., Davenport, S.L., Priluck, I., White, V., et al. 1989. Usher syndrome: an otoneurologic study. Laryngoscope, 99, 73-79.
17. Nuutila, A. 1970. Dystrophia retinae pigmentosa-dysacusis syndrome (DRD): a study of the Usher or Hallgren syndrome. J Genet Hum, 18, 57-88.
18. Pieke Dahl, S., Kimberling, W.J., Gorin, M.B., Weston, M.D., Furman, J.M., et al. 1993. Genetic heterogeneity of Usher syndrome type II. J Med Genet, 30, 843-848.
19. Rosenberg, T., Haim, M., Hauch, A.M. & Parving, A. 1997. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet, 51, 314-321.
20. Smith, R.J., Berlin, C.I., Hejtmancik, J.F., Keats, B.J., Kimberling, W.J., et al. 1994. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet, 50, 32-38.
21. Spandau, U.H. & Rohrschneider, K. 2002. Prevalence and geographical distribution of Usher syndrome in Germany. Graefes Arch Clin Exp Ophthalmol, 240, 495-498.
22. Usher, C.H. 1914. On the inheritance of retinitis pigmentosa with notes of cases. R Lond Ophthalmic Hosp Rev, 19, 130-136.
23. van Aarem, A., Pinckers, A.J., Kimberling, W.J., Huygen, P.L., Bleeker-Wagemakers, E.M., et al. 1996. Stable and progressive hearing loss in type 2A Usher's syndrome. Ann Otol Rhinol Laryngol, 105, 962-967.
24. Van Camp, G. & Smith, R.J. 2002. Hereditary Hearing Loss Homepage. Available at: http://dnalab-wwwuia.ac.be/dnalab/hhh/ (accessed 1 November 2002).
25. Wagenaar, M., van Aarem, A., Huygen, P., Pieke-Dahl, S., Kimberling, W., et al. 1999. Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg, 125, 441-445.
26. Weston, M.D., Eudy, J.D., Fujita, S., Yao, S., Usami, S., et al. 2000. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet, 66, 1199-1210.
27. Von Graefe, A. 1858. Vereinzelte Beobachtungen und Bemerkungen: Exceptionelles Verhalten des Gesichtfeldes bei pigmentartung der Netzhaut. Von Graefe's Arch Klin Exp Ophthalmol, 4, 250-253.